Literature DB >> 9824490

Tissue distribution of the guinea-pig decay-accelerating factor.

K Nishikawa1, S Matsuo, H Tamai, N Okada, H Okada.   

Abstract

MCA44 is a monoclonal antibody (mAb) to guinea-pig decay-accelerating factor (DAF) and, using this mAb, tissue distribution of guinea-pig DAF was studied by immunofluorescence. Guinea-pig DAF was found to be expressed not only on the vascular endothelium but also on different types of cells, such as the tubular epithelium of the kidney, epidermal cells of the skin and synovial lining cells. As there was no significant reduction in staining intensity with MCA44 following treatment with phosphatidylinositol-specific phospholipase C, many guinea-pig DAF molecules expressed in these tissues may be of the transmembrane form.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9824490      PMCID： PMC1364319          DOI： 10.1046/j.1365-2567.1998.00592.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


  32 in total

Review 1.  Decay-accelerating factor: biochemistry, molecular biology, and function.

Authors:  D M Lublin; J P Atkinson
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 2.  The third component of complement: new functions for an old friend.

Authors:  M K Hostetter
Journal:  J Lab Clin Med       Date:  1993-11

3.  Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement.

Authors:  N Okada; R Harada; T Fujita; H Okada
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

4.  Purification of 1F5 antigen that prevents complement attack on homologous cell membranes.

Authors:  R Harada; N Okada; T Fujita; H Okada
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

5.  Relative contribution of contact and complement activation to inflammatory reactions in arthritic joints.

Authors:  J J Abbink; A M Kamp; J H Nuijens; A J Erenberg; A J Swaak; C E Hack
Journal:  Ann Rheum Dis       Date:  1992-10       Impact factor: 19.103

6.  A novel membrane glycoprotein capable of inhibiting membrane attack by homologous complement.

Authors:  N Okada; R Harada; T Fujita; H Okada
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

7.  Murine membrane inhibitor of complement which accelerates decay of human C3 convertase.

Authors:  Y Kameyoshi; M Matsushita; H Okada
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

8.  CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.

Authors:  A Davies; D L Simmons; G Hale; R A Harrison; H Tighe; P J Lachmann; H Waldmann
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

9.  Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1.

Authors:  H Molina; W Wong; T Kinoshita; C Brenner; S Foley; V M Holers
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

10.  Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids.

Authors:  M E Medof; E I Walter; J L Rutgers; D M Knowles; V Nussenzweig
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307
View more
  3 in total

1.  Decay accelerating factor in guinea-pig reproductive organs.

Authors:  C He; M Nonaka; T Tada; T Koji; W Li; N Okada; H Okada
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

2.  Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies.

Authors:  F Lin; Y Fukuoka; A Spicer; R Ohta; N Okada; C L Harris; S N Emancipator; M E Medof
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

3.  Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli.

Authors:  Jennifer White; Petra Lukacik; Dirk Esser; Michael Steward; Naomi Giddings; Jeremy R Bright; Sarah J Fritchley; B Paul Morgan; Susan M Lea; Geoffrey P Smith; Richard A G Smith
Journal:  Protein Sci       Date:  2004-09       Impact factor: 6.725
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.